US$ 28.72
glp-1 hub podcast Hub: Support, Community, and Weight Loss GLP-1 Hub - YouTube
Description
Mounjaro for diabetes) demonstrated significant weight loss in the SURMOUNT-1 trial published in the New England Journal of Medicine (2022), with mean reductions of 1522% depending on dose

et al., 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes, European Heart Journal 2023

Furthermore, GLP-1RAs can increase diuretic and natriuretic actions through changes in renal hemodynamics and inhibition of the sodium-hydrogen exchanger 3 in the renal proximal tubule [56]

assisted in analyzing clinical evidence and drafting the pharmacological section
